Haya Alzeer | Pharmacology | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

 

Haya Alzeer
Researcher Haya Alzeer
Affiliation Saudi Food and Drug Authority
Country Saudi Arabia
Scopus ID 57202029321
Citations 44 by 4 docments
h-index 3
Subject Area Pharmacology
Event International Environmental Scientists Award
ORCID
0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeer’s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeer’s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeer’s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
  2. ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
  3. Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
  4. Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259–264.https://doi.org/10.1087/20120404
  5. Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Dr. Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

PhD candidate, Institute of drug discovery and development, Zhengzhou University, China

Nigatu Tadesse Gebrehiwot is a dedicated clinical pharmacist and PhD candidate in Pharmacology at Zhengzhou University, China 🇨🇳. With a strong background in drug safety, cancer care, and clinical trials, he combines research, patient-centered care, and academic writing to advance pharmaceutical sciences. Fluent in English (CEFR: C2) and well-versed in pharmacotherapy, Nigatu is recognized for his interdisciplinary expertise and contributions to national and international healthcare initiatives 🌐💊.

Profile

Orcid

🎓 Education

Nigatu earned his Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University 🇨🇳 (2016–2019), where he was honored for presenting research at the ISPOR European Congress in Barcelona. He completed his Bachelor of Pharmacy at Mekelle University 🇪🇹 (2009–2014), where he was celebrated as the most outstanding student. His academic journey reflects consistent excellence and passion for clinical research and therapeutic outcomes 📚🏅.

🧪 Experience

Nigatu has held various impactful roles in healthcare and pharmaceutical research. As Principal Scientific Officer at Ethiopia’s Ministry of Health 🇪🇹, he led disease management and national drug therapy protocols. He also served as Technical Manager at CBC Pharmacy, oversaw clinical pharmacy at Teklehaiymanot Hospital, and advised over 50 drug access projects for the Chinese market 🌍. Currently, he is pursuing a PhD in Pharmacology at Zhengzhou University, specializing in drug safety and clinical outcomes 🔬🩺.

🔬 Research Interest

Nigatu’s research interests span methionine metabolism in cancer, therapeutic drug evaluation, clinical trial outcomes, and antimicrobial therapy. He is particularly focused on immunotherapy, functional disease outcome measures, and innovative diagnostic methods. His goal is to improve patient care through translational and evidence-based pharmaceutical research 💡🧬.

🏆 Awards

Nigatu received an award for his research abstract at the 21st European Congress ISPOR in Barcelona, Spain 🇪🇸. He’s been acknowledged nationally and internationally for his scientific contributions and health policy initiatives. His ongoing membership in global societies like ISPOR, ISOPP, and ESMO underlines his excellence in pharmacology and healthcare outcome research 🥇🌍.

📚 Publications

Molecular Alterations in Gastric Intestinal Metaplasia (2025) – Biomedicines, 13(4):964
🔗 Read Article

Folate Species Analysis Challenges – Under revision in Bioanalysis

Methionine Metabolism in Immunotherapy – Under review in Novel Practice in Medical Study

Dioscorea zingiberensis Overview (2018) – Journal of Ethnopharmacology
🔗 Read Article

Toxicity of Dioscorea Extracts in Dogs (2017) – Regulatory Toxicology and Pharmacology
🔗 Read Article

Amide Alkaloid Synthesis and Anticancer Activity (2017) – Journal of Natural Product Research
🔗 Read Article

Wastewater Treatment in Diosgenin Production (2018) – Journal of Cleaner Production
🔗 Read Article

Antibiotic Prescribing in Sierra Leone – Royal Society of Tropical Medicine and Hygiene
🔗 Read Article

Self-Medication in Addis Ababa – Expert Review of Anti-infective Therapy
🔗 Read Article

Survival Time in HIV/TB Co-infection – Value in Health
🔗 Read Article

📝 Conclusion

Mr. Nigatu Tadesse Gebrehiwot presents a strong and well-rounded profile suitable for the Best Researcher Award, especially within clinical pharmacology, health outcomes research, and drug safety. His multidisciplinary expertise, global engagement, and impactful publications showcase his excellence. With continued leadership in original research and enhanced visibility as principal investigator, he can solidify his position among the top-tier researchers internationally.